Acid Apc
 |
No items matching your keywords were found.
Alnylam Down to Neutral - Analyst Blog (Zacks)
We have downgraded our rating on Alnylam Pharmaceuticals, Inc (ALNY) from
Outperform to Neutral with a target price of $11.00 per share.
APC Rehearsal Pt3 "Drunk on Acid Cam"
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.